These results provide novel mechanistic insights into the pathophysiological connection between diabetes‐associated hyperglycemia and PD development, while simultaneously identifying SLC7A11 as a promising therapeutic target for the clinical management of PD in diabetic populations. The gene discussed is SLC7A11; the disease is diabetes mellitus.